
Sign up to save your podcasts
Or


Do people with schizophrenia already have a high risk of metabolic effects early in the course of illness?
This episode discusses health concerns for first-episode patients, including life expectancy, metabolic conditions in drug-naïve patients, the signs of developing insulin resistance, and the approaches for early metabolic changes.
Faculty: Stephen Marder, M.D. Hosts: Jessica Diaz, M.D., Flavio Guzman, M.D.
By Psychopharmacology Institute4.6
269269 ratings
Do people with schizophrenia already have a high risk of metabolic effects early in the course of illness?
This episode discusses health concerns for first-episode patients, including life expectancy, metabolic conditions in drug-naïve patients, the signs of developing insulin resistance, and the approaches for early metabolic changes.
Faculty: Stephen Marder, M.D. Hosts: Jessica Diaz, M.D., Flavio Guzman, M.D.

695 Listeners

76 Listeners

495 Listeners

146 Listeners

302 Listeners

3,342 Listeners

161 Listeners

1,353 Listeners

710 Listeners

557 Listeners

472 Listeners

369 Listeners

717 Listeners

191 Listeners

154 Listeners